title: Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up.
authors.forename: Tanzina
authors.initials: T
authors.lastname: Haque
authors.forename: Karen A
authors.initials: KA
authors.lastname: McAulay
authors.forename: Deirdre
authors.initials: D
authors.lastname: Kelly
authors.forename: Dorothy H
authors.initials: DH
authors.lastname: Crawford
mesh_terms: D001782:Blood Donors; D064987:Cell- and Tissue-Based Therapy / Q000379:methods; D006680:HLA Antigens / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000276:immunology*; D016377:Organ Transplantation / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation*; D014015:Tissue Banks
chemical_list: D006680:HLA Antigens